Isofurosemide,
4818-59-1,
Iso Furosemide,
UNII-V2ZF54Q4LZ,
V2ZF54Q4LZ,
Isolasix,
Furosemide impurity A,
SCHEMBL12418659,
DTXSID30197452,
STL453137,
ZINC65743077,
ACM4818591,
H 20,
FT-0670460,
2-chloro-4-furfurylamino-5-sulfamoyl-benzoic acid,
2-Chloro-4-(furfurylamino)-5-sulfamoylbenzoic Acid,
2-Chloro-4-(2-furanylmethylamino)-5-sulfamoylbenzoic acid,
2-chloro-4-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,
2-chloro-4-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid,
2-Chloro-4-[(furan-2-ylmethyl)amino]-5-sulphamoylbenzoic Acid,
5-(Aminosulfonyl)-2-chloro-4-[(2-furanylmethyl)amino]benzoic Acid,
Furosemide impurity A, European Pharmacopoeia (EP) Reference Standard,
Furosemide Related Compound A, United States Pharmacopeia (USP) Reference Standard,
2-CHLORO-4-N-FURFURYLAMINO -5-SULFAMOYLBENZOIC ACID (Furosemide Related Compound A)(Furosemide Impurity A), Pharmaceutical Secondary Standard; Certified Reference Material,
2-Chloro-4-furfurylamino-5-sulfamoylbenzoic acid,